Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

768 results about "Psoriasis" patented technology

A chronic skin disease which results in scaly, often itchy areas in patches.

Hydrogel loaded with antibacterial polypeptide as well as preparation method and application of hydrogel

The invention discloses hydrogel loaded with antibacterial polypeptide as well as a preparation method and application of the hydrogel. The preparation method of the hydrogel comprises the steps that antibacterial polypeptide and polyethylene glycol dimethacrylate are subjected to a cross-linking reaction, the hydrogel can be obtained, and the antibacterial polypeptide is obtained through polymerization synthesis of a cationic CBL monomer compound and an HBL monomer compound; the hydrogel has remarkable sterilization and anti-biofilm effects, and in-vitro cytotoxicity shows that the antibacterial polypeptide hydrogel product has no inhibition effect on normal cell growth; when the hydrogel dressing is used as a hydrogel dressing and is combined with novobiocin for use, more than 99% of antibacterial effect is achieved in a diabetes wound infection model and a fungal psoriasis infection model; and when being used as a hydrogel preparation to be combined with fluconazole, the compound has the effect of inhibiting growth of more than 99% of fungi in an animal vaginitis model.
Owner:SUZHOU INFINITE DIMENSIONAL LIFE SCI & TECH CO LTD

Sortilin-based lysosome targeting chimera and application thereof

The invention discloses a lysosome targeted chimera based on Sortilin and application thereof. The lysosome targeted chimera comprises a ligand molecule of a lysosome targeted receptor and a ligand molecule of a targeted protein to be degraded, wherein the ligand molecule and the ligand molecule are connected through a linker; the lysosome targeting receptor is Sortilin, and the ligand molecule of the lysosome targeting receptor is a polypeptide targeting the Sortilin; the protein to be degraded is membrane protein or extracellular protein. Furthermore, the polypeptide of the targeted Sortilin is connected with an enzyme response sequence and an integrin receptor targeting sequence. According to the invention, the Sortilin-combined ligand neurotensin is functionally coupled with the neutralizing antibody or polypeptide of overexpression protein in targeted tumor or inflammatory diseases, and the Sortilin-combined ligand neurotensin has obvious treatment gain in malignant solid tumor and psoriasis models. The discovery promotes the transformation potential of the lysosome participating in the biological agent, and provides a dual strategy for realizing accurate degradation through receptor recruitment and microenvironment induction.
Owner:ZHEJIANG UNIV

Application and extraction method of prinsepia utilis royle polysaccharide

The invention discloses application and an extraction method of prinsepia utilis royle polysaccharide, which comprises the following steps: extracting prinsepia utilis royle residues with 95% ethanol at 85 DEG C, filtering, extracting the residues with deionized water at 85-95 DEG C for 2-3 times, merging extracts, performing alcohol precipitation with 90%-95% ethanol at 2-6 DEG C, removing protein through a Sevage method, centrifugally collecting supernate, and freeze-drying to obtain the prinsepia utilis royle polysaccharide. And finally determining the content of the prinsepia utilis royle polysaccharide by using an anthrone-sulfuric acid colorimetric method, wherein the obtained prinsepia utilis royle polysaccharide is used for treating and improving skin lesion of psoriasis. Tests prove that prinsepia utilis royle polysaccharide can significantly improve psoriasis skin lesion, reduce inflammatory factor expression, enhance skin barrier function and increase expression of epidermal related protein, and is helpful for relieving symptoms of psoriasis patients and improving skin conditions.
Owner:FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL UNIV

System and method for evaluating severity of psoriasis

The invention discloses a psoriasis severity assessment system and method, and relates to the technical field of image processing, the system comprises an image segmentation module, a psoriasis skin lesion body surface area measurement module and a psoriasis severity assessment module, the image segmentation module extracts global information of an input image based on a Trans-Unet model, and the input image is subjected to image segmentation; pixel-level segmentation is carried out on the input image; the psoriasis skin lesion body surface area measurement module calculates a skin lesion area proportion according to an image segmentation result, and obtains a psoriasis severity level of each image through an embedded threshold value; and the psoriasis severity assessment module constructs a psoriasis severity assessment model based on the convolutional neural network ConvNeXt, and carries out psoriasis severity assessment. According to the invention, image segmentation and psoriasis severity assessment tasks can be completed intelligently, the workload of medical staff can be reduced, the working efficiency can be improved, the assessment accuracy can be improved, and the cost can be reduced.
Owner:GUANGZHOU HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Phytobacterium plantarum DACN128 for inhibiting malassezia and application of phytobacterium plantarum DACN128

The invention discloses lactobacillus plantarum DACN128 which is preserved in the China Center for Type Culture Collection, the preservation number of the lactobacillus plantarum DACN128 is CCTCC NO: M20241337, and the lactobacillus plantarum DACN128 has a remarkable effect of inhibiting pathogenic malassezia, can be applied to prevention and treatment of skin diseases caused by excessive propagation of malassezia such as seborrheic dermatitis, characteristic dermatitis and psoriasis, and has a good application prospect. The application range of the plant lactobacillus DACN128 is expanded, the utilization value of the plant lactobacillus DACN128 is improved, and a new thought is brought to preparation of related daily washing products for removing dandruff and treating fungal infectious dermatitis.
Owner:SOUTHWEST UNIV

25-Hydroxy-Cholest-5-En-3-Sulfate Choline and Methods for Preparing, and Uses of, Same

25HC3S choline and crystalline 25HC3S choline are described herein. Pharmaceutical formulations of 25HC3S choline such as with crystalline 25HC3S choline and methods of treating or preventing disease with same such as hypercholesterolemia, hypertriglyceridemia, and conditions related to fat accumulation and inflammation (e.g., non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), alcoholic hepatitis, acute kidney injury (AKI), psoriasis, and atherosclerosis) are further disclosed herein. Methods for preparing 25HC3S, including crystalline 25HC3S choline, are also provided.
Owner:MEDICIS PHARMACEUTICAL CORP

Application of polypeptide in treatment of psoriasis

The invention belongs to the technical field of biological medicine, and particularly relates to application of polypeptide in treatment of psoriasis. The amino acid sequence of the polypeptide provided by the invention is SEQ ID NO.1, so that the spleen-body ratio of a psoriasis mouse can be effectively reduced, and the inflammation level in the body can be reduced; the epidermal thickness of psoriasis mice and inflammatory factors in skin lesion tissues can be remarkably reduced, keratinocyte proliferation is reduced, and inflammatory factors released by inflammatory cells recruited to skin lesion positions are reduced. The polypeptide provided by the invention shows certain advantages in the aspects of relieving inflammatory response, promoting tissue repair and the like when being used for treating psoriasis. The invention provides a new method and means for treating psoriasis, and promotes the progress and development of medicine.
Owner:BEIJING LIFE SCIENCE ACADEMY CO LTD

Extraction method and application of plant exosome

The invention discloses a plant exosome extraction method and application thereof, and belongs to the technical field of exosome extraction. The extraction method of the plant exosome comprises the following steps: S1, mixing a plant sample with a buffer solution, performing juicing treatment, and filtering to obtain a crude extract; s2, carrying out continuous flow centrifugal treatment on the crude extract to obtain a refined extract; s3, carrying out concentration treatment on the refined extract to obtain a concentrated solution; and S4, carrying out microfluidic purification treatment on the concentrated solution to obtain the plant exosome. According to the method, the exosome of the plant sample is extracted by adopting a treatment method combining juicing treatment, continuous flow centrifugal treatment, concentration treatment and microfluidic purification treatment, so that large-volume, high-throughput, high-efficiency and low-cost exosome extraction and separation of the plant sample are realized; in addition, it is found for the first time that the panax notoginseng source exosome not only can effectively inhibit expression of inflammatory factors, but also has a good effect on psoriasis treatment.
Owner:THE SECOND AFFILIATED HOSPITAL OF KUNMING MEDICAL UNIV (YUNNAN PROVINCIAL UROLOGY HOSPITAL YUNNAN PROVINCIAL HEPATOBILIARY & PANCREATIC SURGERY HOSPITAL)

Platycodon grandiflorum inulin polysaccharide, preparation method thereof and application of platycodon grandiflorum inulin polysaccharide in preparation of medicine for treating psoriasis

The invention discloses platycodon grandiflorum inulin polysaccharide as well as a preparation method and application thereof in preparation of a medicine for treating psoriasis, the structure of the platycodon grandiflorum inulin polysaccharide is as shown in formula I, the platycodon grandiflorum inulin polysaccharide contains fructose and glucose, and the weight-average molecular weight of the platycodon grandiflorum inulin polysaccharide is 2-10KD. The platycodon grandiflorum inulin polysaccharide disclosed by the invention is remarkable in psoriasis resisting effect, safe, non-toxic and good in biocompatibility, and is expected to be developed into a novel treatment medicine for treating psoriasis. # imgabs0 #
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Double stranded oligonucleotide for modulating JAK1 expression

The present invention relates to double stranded oligonucleotides that are complementary to JAK1, leading to modulation of the expression of JAK1. Modulation of JAK1 expression is beneficial for a range of medical disorders including inflammatory bowel disease, organ transplant rejection, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis (RA), juvenile idiopathic arthritis, psoriasis, dermatitis, diabetic nephropathy, systemic lupus erythematosus (SLE), dry eye disease, cancer, myelofibrosis, and asthma. Also included are compositions comprising the double stranded oligonucleotide and methods of treatment using the double stranded oligonucleotide.
Owner:F HOFFMANN LA ROCHE & CO AG +1

Application of protein nano-selenium hydrogel in preparation of medicine for preventing and treating psoriasis

The invention belongs to the technical field of medicines, and discloses application of protein nano-selenium hydrogel in preparation of a medicine for preventing and treating psoriasis. Compared with nano-selenium gel prepared by a traditional method, the protein nano-selenium hydrogel prepared by the preparation method disclosed by the invention is better in stability, higher in oxidation resistance and anti-inflammatory capacity and better in treatment effect on psoriasis dermatitis.
Owner:CHONGQING MEDICAL UNIVERSITY

Traditional Chinese medicine composition for treating psoriasis as well as preparation method and application thereof

The invention relates to a traditional Chinese medicine composition for treating psoriasis as well as a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following raw materials: herba portulacae, radix sophorae flavescentis, cortex dictamni, honeysuckle flower, fructus kochiae, cortex phellodendri, cacumen biotae, radix paeoniae rubra and radix arnebiae seu lithospermi. The traditional Chinese medicine composition has the advantages of scientific and reasonable formula, synergistic interaction, few components and controllable quality. In the formula, the compatibility of monarch, minister, assistant and guide is scientific and reasonable, anti-inflammatory and immunoregulation compatibility of heat-clearing, blood-cooling and itching-relieving medicines can effectively remove pathogenesis and enhance the itching-relieving effect, the effects of anti-inflammatory, anti-proliferation and local vasoconstriction are achieved, the advantages of effect enhancement and toxicity reduction are achieved, and the risk of relapse can be reduced. Therefore, epithelial tissue repair is promoted, skin keratinization dynamic balance is maintained, relapse of psoriasis is effectively prevented, and pain of patients is reduced.
Owner:GENERAL HOSPITAL OF THE NORTHERN WAR ZONE OF THE CHINESE PEOPLES LIBERATION ARMY

Composite gel with ROS (reactive oxygen species) and pH (potential of hydrogen) dual responsiveness as well as preparation method and application of composite gel

The invention discloses composite gel with ROS and pH dual responsiveness and a preparation method and application thereof.The preparation method comprises the steps that gold nanoparticles are prepared, gold nanostars GNS grow, a surfactant and biguanide drugs are added to obtain drug-loaded gold nanostars GM, a metal organic framework is introduced to obtain drug-loaded nanoparticles GMZ of a core-shell structure, and the composite gel is prepared. And reacting with a TSPBA solution, an astaxanthin solution and a polyvinyl alcohol PVA solution for crosslinking to obtain the ROS and pH dual responsive composite gel. According to the invention, the gold nanostars are used as a photosensitizer to construct the multifunctional composite gel, and the metal organic framework structure degrades under a slightly acidic condition of a psoriasis epithelium microenvironment to release released zinc ions, so that the gel is endowed with various treatment effects, excellent photo-thermal treatment performance and controlled release performance of the zinc ions and drugs. The gel has ROS responsiveness, can remove excessive ROS in a psoriasis microenvironment, and realizes the treatment of oxidation resistance, inflammation resistance and keratinocyte proliferation inhibition of psoriasis by combining with a nano drug delivery system.
Owner:HANGZHOU NORMAL UNIVERSITY

Application of polypeptide in preparation of medicine for treating psoriasis

The invention discloses an application of a polypeptide Apelin-13 in a medicine for treating psoriasis, in particular to psoriasis-like skin lesion. In an imiquimod (IMQ) cream induced mouse psoriasis model, intraperitoneal injection of Apelin-13 can significantly reduce scale, erythema and skin thickness, and can inhibit proliferation of epithelial spine cells. HE staining and immunohistochemical staining are carried out on the skin tissue of an experimental mouse, and the result shows that Apelin-13 can reduce the expression of the psoriasis marker protein K17, the thickness of the surface layer of the back side skin of the experimental mouse and the downward extension of a spinous layer. Experimental mouse serum ELISA (enzyme-linked immunosorbent assay) detection results show that the Apelin-13 can be used for down-regulating IL-17A (interleukin-17A) which is highly expressed in psoriasis. The polypeptide Apelin-13 can be used as a medicine for treating psoriasis, especially a medicine for treating psoriasis-like skin lesion.
Owner:HENAN UNIVERSITY

Application of portulaca oleracea polysaccharide in preparation of medicine for treating psoriasis

The invention firstly discloses application of portulaca oleracea polysaccharide in preparation of the medicine for treating psoriasis, the medicine for treating psoriasis can improve psoriasis-like skin injury and reduce skin tissue inflammation, and the portulaca oleracea polysaccharide is single-component pure polysaccharide extracted from portulaca oleracea and purified. The monosaccharide composition is composed of all or several monosaccharides of rhamnose, arabinose, galactose, glucose, xylose and galacturonic acid, and the molecular weight of the monosaccharide composition is 80-200 kDa. The invention further discloses application of the purslane polysaccharide in preparation of drugs for treating psoriasis and application of the purslane polysaccharide in preparation of cosmetics and medical auxiliary materials for relieving psoriasis-like skin injury. The purslane polysaccharide disclosed by the invention is high in purity, clear in structure and high in safety, has a good psoriasis treatment effect, is superior to dexamethasone in curative effect, can be used as a skin external medicine, a cosmetic, a medical instrument and a medical auxiliary material, and has various potential application values.
Owner:SUZHOU UNIV

Application of vitamin K3 in preparation of medicine for treating psoriasis

The invention belongs to the technical field of biological medicines, and discloses application of vitamin K3 in preparation of a medicine for treating psoriasis. The invention finds that the compound vitamin K3 can obviously inhibit the activation of the STING downstream immune pathway and has an inhibition effect on the activation of the STING pathway. A mouse psoriasis model is formulated according to the absorption and metabolism characteristics of the inhibitor VK3, and it is proved that the VK3 can significantly inhibit the process of psoriasis and up-regulation of an STING pathway at an affected part in a transdermal drug delivery mode. The STING pathway does not belong to a main pathway affecting the course of disease in most non-immunodeficient inflammatory diseases, so that a better treatment effect may be generated by using the STING pathway in combination with a direct treatment drug (such as an IL-17A antibody for psoriasis). The vitamin K3 is simple in chemical structure, mature in production process and low in preparation cost, has more remarkable price advantage compared with biological agents and small-molecule targeting drugs, and has high popularization value and application prospects.
Owner:SUN YAT SEN UNIV

Leixihaokang, preparation method therefor, and use thereof

The present invention belongs to the field of traditional Chinese medicines, and particularly relates to Leixihaokang, a preparation method therefor, and use thereof. The Leixihaokang of the present invention is prepared from the following active pharmaceutical ingredients in parts by weight: 10 parts of Tripterygium glycosides and 0.1-1.3 parts of Artemisia annua extract. According to the present invention, animal experiments prove that the Leixihaokang can ameliorate renal damage in nephrotic syndrome caused by adriamycin, reduce the occurrence of proteinuria, and reduce the apoptosis of renal tissue cells. Meanwhile, the Leixihaokang of the present invention has a good inhibitory effect on renal, hepatic, splenic, and cardiac toxicity in the treatment process of nephrotic syndrome. According to the present invention, animal experiments also prove that the Leixihaokang can ameliorate skin injury in imiquimod-induced psoriasis, reduce inflammatory infiltration and alleviate skin damage. Meanwhile, the Leixihaokang has a certain degree of inhibitory effect on the hepatic and reproductive system toxicity in the treatment process of psoriasis.
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE +2

Therapeutic use of fibroblasts for the treatment of psoriasis

Embodiments of the disclosure include methods and compositions for the treatment of psoriasis. In specific embodiments, fibroblasts, and / or fibroblast-derived materials, are utilized in at least some cases to affect the immune response of the individual in order to reduce the pathogenic levels of immune cells or cytokines and / or chemokines excreted by those immune cells.
Owner:FIBROBIOLOGICS INC

Methods of achieving safe and sustained control of il-17-dependent conditions in subjects responsive to treatment with an Anti-il 17a / f nanobody

Disclosed herein are methods of treating psoriasis and other IL-17-dependent conditions with an anti-interleukin 17A / F nanobody for approximately 24 weeks, followed by withdrawal of treatment in responding patients with the anti-interleukin 17A / F nanobody for a period of at least 4-20 weeks. Disease modification may be achieved by no later than week 24 with the anti-interleukin 17A / F nanobody such that responders may demonstrate sustained normalization of peripheral and / or cutaneous biomarkers such as IL-17A, IL-17F, and / or IL-22. Treatment methods as contemplated herein which have been paused may be re-started based on the subject's condition. Treatment beyond 24 weeks also achieves unexpectedly high efficacy in responders who have not quite reached full skin clearance in the initial treatment period.
Owner:MOONLAKE IMMUNOTHERAPEUTICS AG

TL1a associated antibody compositions and methods of use

The disclosure herein relates to the development and production of novel antibodies and antigen binding fragments thereof that bind TL1 A and that are useful in the treatment, prevention and diagnosis of a disease, disorder or inflammation including, for example, autoimmune diseases including rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, systemic lupus erythematosus, asthma, ulcerative colitis, Crohn's disease, psoriasis, primary biliary cirrhosis, primary biliary cholangitis, ankylosing spondylitis, and fibrosis including intestinal fibrosis, pulmonary fibrosis, and liver fibrosis. Some of the elements of final antibody structure being designed de novo by a computer system and its data training set without reference to a specific reference molecule.
Owner:ABSCI CORPORATION

Mouse model construction method for psoriasis research based on dihydroxyisobutyrylation modification of SBSN 600-site lysine

The invention relates to a mouse model construction method for psoriasis research based on dihydroxyisobutyrylation modification of SBSN 600 site lysine. The mouse model construction method comprises the following steps: 1, constructing a plasmid comprising an SBSN gene sequence and a DNA fragment of which the 600 site of the SBSN sequence is mutated from lysine (K) to threonine (T); 2, culturing the mouse embryonic stem cells; step 3, carrying out electric transformation on the embryonic stem cells; 4, screening the medicines; 5, calling and culturing the embryonic stem cells screened in the step 4; step 6, injecting the embryonic stem cells called and cultured in the step 4 into a mouse blastocyst, then culturing the mouse blastocyst, and transplanting the cultured blastocyst into the uterus of a pseudopregnant female mouse, so that the mouse generated by delivery of the female mouse is a chimeric mouse; and 7, breeding the chimeric mouse and identifying the genotype of the mouse through PCR (Polymerase Chain Reaction).
Owner:TAIYUAN CENT HOSPITAL

Cosmetic nail formulations

A number of medical and lifestyle-related factors can lead to toe and / or finger-nails becoming discoloured, thickened, brittle and dry. Nail fungus, psoriasis, sports injury, use of nail varnish are examples of such factors. The present invention relates to a topical cosmetic nail formulation, uses of the formulation on a nail and a cosmetic method for improving the appearance of a nail.
Owner:NOVABIOTICS LTD

Construction and application of mesoporous polydopamine nano preparation loaded with ultra-small nano enzyme

The invention belongs to the field of biomedical materials, and discloses a preparation method and application of a mesoporous polydopamine nano preparation loaded with ultra-small nano enzyme. The nano preparation takes mesoporous polydopamine nanoparticles as a carrier skeleton and is combined with ultra-small nano enzyme through an in-situ reaction: the mesoporous polydopamine nanoparticles can efficiently carry drugs and accurately deliver the drugs to inflammatory tissues such as psoriasis, gout, colitis and the like by virtue of a modified targeting ligand by virtue of high specific surface area, biocompatibility and modifiability; the ultra-small nano enzyme has catalytic activity of catalase and the like, and can remove active oxygen and relieve oxidative stress. The two components are combined to achieve a synergistic effect, so that the catalytic efficiency of the enzyme is improved by virtue of the characteristics of the carrier, the high activity of the enzyme under different conditions is maintained by virtue of the stability of the carrier, and the platform can synchronously realize targeted delivery, enzymatic treatment and drug controlled release, and has a wide application prospect in the fields of inflammatory disease intervention and wound repair. And an efficient, accurate and low-toxicity universal treatment strategy is provided for chronic inflammatory diseases.
Owner:CHONGQING MEDICAL UNIVERSITY

Pulsatilla saponin b4 derivative, preparation method therefor, and use thereof

PCT designated stage expiredWO2025092276A1Organic active ingredientsAntipyreticElectrophilic additionEczematous rash
Disclosed are a Pulsatilla saponin B4 derivative, a preparation method therefor, and a use thereof. A compound Pulsatilla saponin B4 (referred to as B4 or AB4) is used as a raw material, a nucleophilic substitution reaction, an electrophilic addition reaction, an esterification reaction, or an amidation reaction is separately performed on a C-19 exocyclic double bond or a C-28 carboxyl group to prepare a derivative, and the derivative is used as an active ingredient to prepare a drug having anti-inflammatory and immunomodulatory effects. In the present invention, it is disclosed for the first time that the B4 derivative has the effect of treating inflammatory diseases such as inflammatory bowel disease, atopic dermatitis, eczema, and psoriasis, and the effect is superior to that of B4 or a clinically common drug. In addition, it is also disclosed for the first time that most B4 derivatives do not show obvious cytotoxicity to macrophages, and can reduce the level of P-IκBa protein in LPS and ATP-induced macrophage NF-κB signaling pathways, inhibit the activation of NLRP3 signaling pathways and obviously reduce the level of Pro-IL-1β (p<0.05), i.e., inhibiting the activation of an inflammasome pathway, and the effect is superior to that of B4. These results show that the B4 derivative of the present invention has better anti-inflammatory activity.
Owner:SUZHOU UNIV

Application of hylarana guentheri multifunctional polypeptide Cak-HG in preparation of medicine for treating psoriasis

The invention provides an application of Cath-HG in preparation of a medicine for preventing and / or treating psoriasis. Experiments prove that Cath-HG has a good curative effect on an imiquimod-induced mouse psoriasis model, can improve skin injury, reduce PASI score, reduce inflammatory cytokine mRNA level, reduce spleen coefficient, recover the number of platelets and neutrophils, inhibit platelet activation and platelet-neutrophil compound formation, reduce neutrophil infiltration and activation, and can be used for treating psoriasis. The release of extracellular traps of neutrophils is inhibited.
Owner:SOUTHERN MEDICAL UNIVERSITY

A traditional Chinese medicine composition for treating psoriasis and its preparation method and application

The present invention relates to a traditional Chinese medicine composition for treating psoriasis, and its preparation method and use. The traditional Chinese medicine composition is prepared from the following raw materials: Portulaca oleracea, Sophora flavescens, Dictamni bark, Honeysuckle, Kochia scoparia, Phellodendron amurense, Platycladus orientalis leaves, Paeonia lactiflora, and Lithospermum officinale. The traditional Chinese medicine composition of the present invention has a scientific and reasonable formulation, synergistic efficacy, a small number of ingredients, and controlled quality. The combination of monarch, minister, adjuvant, and envoy in the present invention's formulation is scientific and reasonable. The combination of anti-inflammatory and immunomodulatory heat-clearing, blood-cooling, and antipruritic drugs can effectively eliminate the cause of the disease and enhance the antipruritic effect, exerting anti-inflammatory, antiproliferative, and local vasoconstrictive effects, with the advantages of increased efficacy and reduced toxicity, and can reduce the risk of recurrence. This promotes epithelial tissue repair, maintains the dynamic balance of skin keratinization, effectively prevents the recurrence of psoriasis, and reduces the suffering of patients.
Owner:GENERAL HOSPITAL OF THE NORTHERN WAR ZONE OF THE CHINESE PEOPLES LIBERATION ARMY